Intelligent Bio Solutions Inc. (INBS) NASDAQ

1.22

+0.02(+1.67%)

Updated at May 09 09:53AM

Currency In USD

Intelligent Bio Solutions Inc.

Address

142 West 57th Street

New York, NY 10019

United States of America

Phone

646 828 8258

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

50

First IPO Date

December 23, 2020

Key Executives

NameTitlePayYear Born
Mr. Harry SimeonidisPresident & Chief Executive Officer393,2201968
Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip LawChief Financial Officer289,8091962
Anna TurkingtonVice President of Marketing0N/A
Mr. Doug HeathVice President of Global Sales0N/A
Callistus SequeiraVice President of Global Quality & Operations0N/A

Description

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.